A preparative-scale regiospecific conversion of 10,11-dimethoxyaporphine to isoapocodeine was conducted with Cunninghamella elegans ATCC 9245. This biotransformation proceeded quantitatively in suspensions and was pH dependent. The influence of antioxidants on the conversion was studied. Attempts to preserve the activity of isolated C. elegans cells by a number of methods were unsuccessful.
There is considerable interest in the development of microbial systems capable of conducting specific type reactions of general synthetic utility (6, 8, 13, 14, 16, 25) . When applied to drugs and other xenobiotics, metabolites from microbial transformations can often be obtained that are also observed in mammalian systems (23) . Although de novo synthesis of drug metabolites may be used in some cases, microbial systems show several advantages when used (20, 23) .
Recent interest in apomorphine (compound 1) stems from its usefulness in the experimental treatment of Parkinson's disease (9) and a number of other disorders (3, 4) . In mammalian systems, apomorphine undergoes methylation (7) and glucuronidation (15) primarily at the 10-position. A rat liver catechol O-methyltransferase preparation produced a mixture of the 10-methylated product, apocodeine (compound 2), and its l1-methylated isomer, isoapocodeine (compound 3), in a ratio of 81:1 (7) . Whereas apocodeine (compound 2) can be conveniently prepared by the monomethylation of compound 1 (7) or by chemical O-demethylation of 10,11-dimethoxyaporphine (compound 4) (1), the isomeric phenol, compound 3, is much more difficult to obtain. Rosazza et al. (18) recently reported that Cunninghamella elegans ATCC 9245 (The culture used in this study was inadvertently reported [18] as C. blakesleeana ATCC 9245 which is correctly C. elegans ATCC 9245. The one used in this study represents a subtransfer of the organism reported [18] .) is capable of specifically O-demethylating compound 4 at the less sterically hindered C-10 methoxyl function. The preparative scale production of compound 3 with C. elegans has been investigated and is the subject of this report. Furthermore, the influence of antioxidants and conditions for cell suspension transformations have also been evaluated. The structure of compounds 1 through 4 is shown in Fig. 1 .
MATERIALS AND METHODS
Analytical methods. Nuclear magnetic resonance spectra were obtained with a Perkin-Elmer model R124 spectrometer using tetramethylsilane as the internal standard. Mass spectra were obtained on a Bell and Howell model 21-491 mass spectrometer. Gas chromatographic (GC) analyses were performed with a Shimadzu GC-4BM gas chromatograph equipped with dual-flame ionization detectors. A glass column (76 by 0.3 cm, internal diameter) containing 3% OV-17 on 100-120 Chromosorb W-HP (Analabs Inc.) was used with a column temperature of 190°C and carrier gas (N2) flow of 50 ml/min. All compounds were derivatized with heptafluorobutyric anhydride (Aldrich) before analysis, as described previously (2) .
Thin-layer chromatography was performed on analytical Silica Gel GF254 plastic plates (Brinkmann Instruments Inc.), which were developed by using systems described earlier (12 Preparative-scale production of isoapocodeine. The stage II fermentation was conducted in five 2,800-ml Fermbach flasks each containing 560 ml of medium A. A total of 1.4 g of compound 4 was dissolved in 5.6 ml of dimethylformamide and distributed evenly among the flasks. Ascorbic acid was added in sterile water (0.33 g/ml) to a level of 2 mg/ml in the culture medium After 3 days of incubation, thin-layer chromatographic and GC analyses of culture extracts indicated complete conversion. The mycelium and medium were separated by ifitration and extracted separately. The medium was adjusted to pH 8.0 with 1 N NaOH and exhaustively extracted with ether. The ether (5 liters) was washed once with water, reduced to 400 ml, and extracted with 1 N HCI (3x 250 ml). The aqueous extract was adjusted to pH 8.0 with potassium carbonate and extracted exhaustively with ether. The ether extract was dried with anhydrous Na2SO4 and concentrated to dryness in vacuo. GC and thin-layer chromatographic analyses of the final extract indicated pure isoapocodeine (compound 3), which was converted to its HCI salt to give 880 mg (59% yield) of compound 3-HCl. Repeated crystallization from absolute ethanol gave white crystals with a melting point of 238 to 241°C (reported, 243 to 248°C) (7) . Spectral analyses were consistent in every respect with those reported for isoapocodeine (7, 18 18 .0 min (see Fig. 2 ).
Quantitation of compound 3 was conducted by using peak height ratios of isoapocodeine (compound 3)/boldine versus concentration of compound 3. Calibration curves were prepared by plotting peak height ratios of the standards versus the concentration of compound 3 in the final acetonitrile solution. Leastsquares regression was used to determine the best-fit line for the data obtained from standards (correlation coefficient -0.998; y intercept Z 0). Absolute recoveries of compounds 3 and 4 were 90% using the procedure described, and final calculated yields were adjusted accordingly.
Attempted transformation of compound 4 by using conidia of C. elegans Ten potato dextrose agar (Difco) petri dishes were inoculated with C. elegans and allowed to incubate at 23°C for 7 days. Conidia were harvested by two separate additions of 10 ml of a sterile 0.01% Tween 80 solution and agitation with a sterile glass spatula, and the resulting suspension was filtered twice through sterile glass wool to remove mycelial fragments. The suspension was centrifuged for 10 (-5°C) before lyophilization.
Acetone powders of lyophilized cellular materials were either used immediately or stored under specified conditions for 1 week. For evaluation of enzymatic activity, frozen samples were thawed at room temperature and washed with phosphate buffer (0.2 M, pH 7.0) before use. Buffer was slowly added to reconstitute acetone-dried powders and lyophflized samples, followed by washing with buffer. The resulting cells were incubated in 0.2 M phosphate buffer (pH 4.5) and analyzed as described above for cell suspension studies.
RESULTS AND DISCUSSION
As reported earlier (18), 10,11-dimethoxyaporphine (compound 4) may be selectively modified by a number of microorganisms. In an analytical study with C. elegans, a regiospecific, quantitative conversion to isoapocodeine (compound 3) was observed. In the present study, a preparative-scale conversion was undertaken to prepare sufficient compound 3 to facilitate ongoing mammalian metabolism studies and as a synthetic intermediate. These studies were greatly facilitated by a recently developed GC assay, capable of separating compounds 1 through 3 as their heptafluorobutyryl derivatives and compound 4 (2) (Fig. 2) . C. elegans quantitatively converts compound 4 to isoapocodeine (3) . In a preparative-scale experiment, a 59% yield was obtained from the filtered culture medium, representing the first preparation of compound 3 in high yield. Chemical methods for mono-O-demethylation of 10,11-dimethoxyaporphine (1) are high yielding but lead exclusively to apocodeine (compound 2). Thus, biotransformation of compound 4 by C. elegans represents the only specific route to isoapocodeine.
Control of pH. Studies with C. elegans indicated that significant conversion of compound 4 to compound 3 occurred only after the pH of the medium dropped below 6.50. Although it was previously reported (18) Use of antioxidants. Antioxidants have been used to prevent the air oxidation of labile fermentation products (19) . It is necessary, however, to show that the antioxidant does not interfere with the desired reaction. Isoapocodeine is an air-labile product, and hence, a number of antioxidants were evaluated for their ability to stabilize the product without interfering with its formation by C. elegans. On the basis of parallel metabolism studies being conducted in our laboratory (12, 21) and the work of other investigators (11, 19) 
